Staphylococcus aureus lipoteichoic acid synthesis pathway (LTA synthesis pathway)

The Staphylococcus aureus lipoteichoic acid (LTA) synthesis pathway is a vital biosynthetic route responsible for the assembly of LTA, a major cell wall component in Gram-positive bacteria [1]. This pathway involves several key enzymes, including YpfP, which synthesizes the glycolipid anchor, LtaA, which flips the anchor to the outer leaflet of the membrane, and LtaS (lipoteichoic acid synthase), which polymerizes glycerol phosphate units onto the anchor [2]. LTA is essential for maintaining cell wall integrity, regulating autolysins, and sequestering divalent cations like magnesium, which are crucial for enzymatic functions [3]. In S. aureus, LTA is indispensable for growth, and its absence leads to severe defects in cell division and increased susceptibility to host immune factors [4]. As a pathogen-associated molecular pattern (PAMP), LTA also triggers inflammatory responses by binding to host Toll-like receptor 2 (TLR2), contributing to the pathology of sepsis and skin infections [5]. Consequently, the LTA synthesis pathway is a prominent target for the development of new antibiotics, with compounds like teixobactin and specific LtaS inhibitors showing efficacy against methicillin-resistant S. aureus (MRSA) [6]. Citations: [1] Gründling & Schneewind (2007) PNAS; [2] Percy & Gründling (2014) Nat Rev Microbiol; [3] Vickery et al. (2018) J Biol Chem; [4] Oku et al. (2009) J Bacteriol; [5] Schroder et al. (2003) J Biol Chem; [6] Ling et al. (2015) Nature.

Other names

LTA biosynthesis pathwayLipoteichoic acid biosynthesisStaphylococcus aureus LTA pathway

Inhibition of the polymerization of glycerol phosphate units by the enzyme LtaS or inhibition of the synthesis and translocation of the glycolipid anchor (Glc2-DAG) by YpfP and LtaA, leading to cell wall instability and bacterial death [2, 3].